Literature DB >> 9468189

Coronary hemodynamics in endothelial NO synthase knockout mice.

A Gödecke1, U K Decking, Z Ding, J Hirchenhain, H J Bidmon, S Gödecke, J Schrader.   

Abstract

For the specific analysis of endothelial NO synthase (eNOS) function in the coronary vasculature, we generated a mouse homozygous for a defective eNOS gene (eNOS-/-). Western blot as well as immunohistochemical staining revealed the absence of eNOS protein in eNOS-/- mice. Aortic endothelial cells derived from eNOS-/- mice displayed only background levels of NOx formation compared with wild-type (WT) cells (88 versus 1990 pmol NOx x h-1/mg protein-1). eNOS-/- mice were hypertensive (mean arterial pressure, 135 +/- 15 versus 107 +/- 8 mm Hg in WT) without the development of cardiac hypertrophy. Coronary hemodynamics, analyzed in Langendorff-perfused hearts, showed no differences either in basal coronary flow or in maximal and repayment flow of reactive hyperemia. Acute NOS inhibition with Nomega-nitro-L-arginine methyl ester (L-NAME) in WT hearts substantially reduced basal flow and reactive hyperemia. The coronary response to acetylcholine (ACh) (500 nmol/L) was biphasic: An initial vasoconstriction (flow, -35%) in WT hearts was followed by sustained vasodilation (+190%). L-NAME significantly reduced vasodilation in WT hearts (+125%) but did not alter the initial vasoconstriction. In eNOS-/- hearts, the initial vasoconstriction was augmented (-70%), whereas the ACh-induced vasodilation was not affected. Inhibition of cyclooxygenase with diclofenac converted the ACh-induced vasodilation into vasoconstriction (-49% decrease of basal flow). This effect was even more pronounced in eNOS-/- hearts (-71%). Our results demonstrate that (1) acute inhibition of eNOS reveals a role for NO in setting the basal coronary vascular tone as well as participation in reactive hyperemia and the response to ACh; (2) chronic inhibition of NO formation in eNOS-/- mutant mice induces no changes in basal coronary flow and reactive hyperemia, suggesting the activation of important compensatory mechanisms; and (3) prostaglandins are the main mediators of the ACh-induced vasodilation in both WT and eNOS-/- mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468189     DOI: 10.1161/01.res.82.2.186

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  78 in total

Review 1.  Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.

Authors:  R D Rudic; W C Sessa
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

Review 2.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

3.  Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors.

Authors:  Peter B Anning; Barbara Coles; Jonathan Morton; Haibin Wang; Jashim Uddin; Jason D Morrow; Sudhansu K Dey; Lawrence J Marnett; Valerie B O'Donnell
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

4.  Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles.

Authors:  David G Ingram; Sean C Newcomer; Elmer M Price; Kevin E Eklund; Richard M McAllister; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-26       Impact factor: 4.733

Review 5.  Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits.

Authors:  Ajay Machha; Alan N Schechter
Journal:  Eur J Nutr       Date:  2011-05-31       Impact factor: 5.614

6.  Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.

Authors:  Dong Sun; Azita J Cuevas; Katherine Gotlinger; Sung Hee Hwang; Bruce D Hammock; Michal L Schwartzman; An Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

7.  Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle.

Authors:  Iman Momken; Dominique Fortin; Bernard Serrurier; Xavier Bigard; Renée Ventura-Clapier; Vladimir Veksler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

8.  Effects of chronic nitric oxide synthase inhibition on endothelium-dependent and -independent relaxation in arteries that perfuse skeletal muscle of swine.

Authors:  S C Newcomer; J C Taylor; R M McAllister; M H Laughlin
Journal:  Endothelium       Date:  2008 Jan-Feb

9.  The effect of salt on renal damage in eNOS-deficient mice.

Authors:  Geraldine Daumerie; Lakeesha Bridges; Sadiqa Yancey; Wendell Davis; Paul Huang; Joseph Loscalzo; Mildred A Pointer
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

10.  Uncoupled eNOS annihilates neuregulin-1β-induced cardioprotection: a novel mechanism in pharmacological postconditioning in myocardial infarction.

Authors:  Bernd Ebner; Stefan A Lange; Thomas Eckert; Clementine Wischniowski; Annette Ebner; Rüdiger C Braun-Dullaeus; Christof Weinbrenner; Carsten Wunderlich; Gregor Simonis; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2012-10-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.